Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
27 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250827237928/en/Incyte-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4
25 Aug 2025
// CONTRACTPHARMA
https://www.contractpharma.com/breaking-news/incyte-taps-soni-basi-as-evp-and-chief-human-resources-officer/
19 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250819694539/en/Incyte-to-Present-at-Upcoming-Investor-Conferences
06 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/06/3128350/0/en/Actuate-Therapeutics-To-Collaborate-with-Incyte-Corporation-and-the-University-of-Pittsburgh-on-Clinical-Trial-of-Elraglusib-in-Combination-with-Retifanlimab-and-mFOLFIRINOX-in-Pat.html
29 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250729918292/en/Incyte-Reports-2025-Second-Quarter-Financial-Results-and-Provides-Updates-on-Key-Clinical-Programs
24 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250724746953/en/Incyte-To-Present-Initial-Data-for-its-TGFR2PD-1-directed-Bispecific-Antibody-INCA33890-and-its-Selective-Inhibitor-of-G12D-mutated-KRAS-INCB161734-at-the-European-Society-of-Medical-Oncology-ESMO-Congress-2025
Inspections and registrations
ABOUT THIS PAGE